'Molecular fingerprinting' will improve monitoring of surgical patients, experts say

May 18, 2011, Imperial College London

Chemical screening technologies will help doctors to monitor surgical patients before, during and after operations, providing better targeted care and treatment, say Imperial College London experts in an article published in The Lancet today.

Scientists use and to determine the of a sample. Studies have shown that using these technologies can produce a “molecular fingerprint” of a biological sample, which could provide useful diagnostic information about which parts of tissue are diseased, how severe a disease is, and what the effects of particular therapies might be.

The world’s first Centre for Surgical Metabonomics, which opened at Imperial College London earlier this year, is already enabling researchers to apply this kind of analysis in a hospital setting. Teams are using nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry to analyse body fluids and tissue samples from patients undergoing surgery at Imperial College Healthcare NHS Trust, to investigate how these tools could be used to tailor treatment and care to individual patients. Led by Imperial’s Professor Jeremy Nicholson and Professor Lord Ara Darzi, scientists here have been focusing on diagnosing patients in real-time on the operating table.

Now, Professors Nicholson and Darzi are planning to extend this approach to monitor the entire “patient journey”, helping doctors to choose the best treatment options before, during, and after an operation. They hope their teams will be able to begin analysing samples from patients at different stages of treatment later this year, when a new centre is due to open featuring two high field NMR spectrometers. This multimillion pound clinical phenotyping centre is the result of a partnership between Imperial, the National Institute for Health Research and Bruker, a major manufacturer of analytical instruments.

"We are using powerful metabolic screening tools to give doctors more information about the patient’s physiology and their response to treatment,” said Professor Nicholson, Head of the Department of Surgery and Cancer at Imperial. “This is a bold step in translational medicine that will help optimise the management of individual patients.

"The patient screening paradigm is based on many years of basic science research in our computational medicine unit at Imperial. We believe that we’re now ready to translate that science into most areas of hospital patient care.

“We intend to use the approach to monitor cancer patients and patients in intensive care. The new diagnostic information will help to manage patients with rapidly changing or highly complex disease conditions. Ultimately we hope to save lives as well NHS money with these new methods.”

Professor Darzi, Chair of the Institute of Global Health Innovation at Imperial, said: “The work that we are conducting at the Centre for Surgical Metabonomics will unquestionably bring us closer to the ultimate goal of personalised surgical healthcare. Until now the practical application of bio-analytical technologies to surgery has presented a challenge, and the strength of metabolic profiling is that it can provide relevant and interpretable data in a time-frame short enough to be of practical use for the clinician. We anticipate that metabolic phenotyping will revolutionise the way we map the surgical patient journey. It will provide us with information before, during and after surgery, ensuring that we deliver surgical care that is truly customised to each patient’s unique metabolic makeup.”

Research projects at the Centre are being funded by Imperial’s Comprehensive Biomedical Research Centre. Imperial’s is one of five Comprehensive Biomedical Research Centres in the UK; it was awarded to Imperial College Healthcare by the National Institute for Health Research following a national competition. The new laboratory forms part of the Academic Health Science Centre, a unique partnership between the Trust and Imperial College London, which aims to improve the quality of life of and populations by taking new discoveries and translating them into new therapies as quickly as possible.

More information: www.thelancet.com/journals/lan … (11)60171-2/fulltext

Related Stories

Recommended for you

Forces from fluid in the developing lung play an essential role in organ development

January 23, 2018
It is a marvel of nature: during gestation, multiple tissue types cooperate in building the elegantly functional structures of organs, from the brain's folds to the heart's multiple chambers. A recent study by Princeton researchers ...

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.